DavenportA.. Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially replacement solutions in patients with acute renal failure.Int J Artif Organs2008; 31(1): 3–5.
2.
BouchardJ., MehtaR.L.. Acid-base disturbances in the intensive care unit: current issues and the use of continuous renal replacement therapy as a customized treatment tool.Int J Artif Organs2008; 31(1): 6–14.
3.
EgiM., NakaT., BellomoR., LangenbergC., LiW., FealyN., BaldwinI.. The acid-base effect f changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration.Int J Artif Organs2008; 31(3): 228–36.
4.
NakaT., BellomoR., MorimatsuH., RocktaschelJ., WanL., GowP., AngusP.. Acid-base balance in combined severe hepatic and renal failure: a quantitative analysis.Int J Artif Organs2008; 31(4): 288–94.
5.
SchneiderM., LiefeldtL., SlowinskiT., PetersH., NeumayerH-H, MorgeraS.. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius® dialysis system.Int J Artif Organs2008; 31(1): 43–38.
6.
Hernandez-JarasJ., Torregrosa de JuanE., Pons-PradesR., Rius-PerisA., Fenollosa-SegarraM.A.. Switching from three times a week to short daily online hemodiafiltration: effects on acid-base balance.Int J Artif Organs2008; 31(3): 237–43.
7.
MangiaA., BurraP., CiancioA., FagiuoliS., GuidoM., PicciottoA., FabriziF.. Hepatitis C infection in patients with chronic kidney disease.Int J Artif Organs2008; 31(1): 15–33.
8.
FabriziF., MarzanoA., MessaP., MartinP., LamperticoP.. Hepatitis B virus infection in the dialysis population: current perspectives.Int J Artif Organs2008; 31(5): 386–94.
9.
CarrieroD., FabriziF., UrielA.J., ParkJ., MartinP., DieterichD.T.. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin.Int J Artif Organs2008; 31(4): 295.
10.
MolinoC., FabbianF., CozzolinoM., LonghiniC.. The management of viral hepatitis in CKD patients: an unresolved problem.Int J Artif Organs2008; 31(8): 683–96.
11.
FabriziF., MessaP., MartinP.. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight.Int J Artif Organs2008; 31(12): 1004–16.
ArciolaC.R.. Still stuck in the slime.Int J Artif Organs2008; 31(9): 749–51.
18.
MontanaroL., CampocciaD., ArciolaC.R.. Nanostructured materials for inhibition of bacterial adhesion in orthopedic implants: a mini-review.Int J Artif Organs2008; 31(9): 771–76.
19.
ShiZ.L., ChuaP.H., NeohK.G., KangE.T., WangW.. Bioactive titanium implant surfaces with bacterial inhibition and osteoblast function enhancement properties.Int J Artif Organs2008; 31(9): 777–85.
20.
del PozoJ.L., RouseM.L., PatelR.. Bioelectric effect and bacterial biofilms. A systematic review.Int J Artif Organs2008; 31(9): 786–95.
21.
KiranM.D., GiacomettiA., CirioniO., BalabanN.. Suppression of biofilm related, device-associated infections by stapphilococcal quorum sensing inhibitors.Int J Artif Organs2008; 31(9): 761–70.
22.
RohaniL., KarbalaieK., VahdatiA., HatamiM., Nasr-EsfahaniM.H., BaharvandH.. Embryonic stem cell sphere: a controlled method for production of mouse embryoniv stem cell aggregates for differentiation.Int J Artif Organs2008; 31(3): 258–65.
23.
KazemnejadS., AllamehA., seolemaniM., GareghbaghianA., MohammadiY., AmirizadehN., EsmaeliS.. Functional hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel 3-dimensional biocompatile nanofibroius scaffold.Int J Artif Organs2008; 31(6): 500–7.
24.
De GirolamoL., SartoriM.F., ArrigoniE., RimondiniL., AlbisettiW., einsteinR.L., BriniA.T.. Human adipose-derived stem cells as future tools in tissue engineering: osteogenic differentiation and cell-scaffold interaction.Int J Artif Organs2008; 31(6): 467–79.
25.
SekiyaK., NishimuraM., SuehiroF., NishimuraH., HamadaT., KatoY.. Enhancement of osteogenesis by concanavalin A in human bone marrow mesenchymal stem cell cultures.Int J Artif Organs2008; 31(8): 708–15.
26.
Del GaudioC., GrigioniM., BiancoA., De AngelisG.. Electrospun bioresorbable heart valve scaffold for tissue engineering.Int J Artif Organs2008; 31(2): 68–75.
27.
BoschettiF., TomeiA.A., TurriS., SwartzM.A., LeviM.. Design, fabrication, and characterization of a composite scaffold for bone tissue engineering.Int J Artif Organs2008; 31(8): 697–707.
28.
PukkinenH.J., TituV., ValonenP., HamailainenE-R, LammiM.J., KivirantaI.. Recombinant human type II collagen as a material for cartilage tissue engineering.Int J Artif Organs2008; 31(11): 960–9.
29.
AokiK., MizumotoH., NakazawaK., FunatsuK., KajiwaraT.. Evaluation of a hybrid artificial liver lobule-like structure in rats with liver failure.Int J Artif Organs2008; 31(1): 55–61.
30.
CandianiG., RaimondiM.T., AuroraR., Lagana'K., DubiniG.. Chondrocyte response to high regimes of cyclic hydrostatic pressure in 3-dimensional engineered construct.Int J Artif Organs2008; 31(6): 190–9.
31.
TsuangY-H, LinY-S, ChenL-T, ChengC-K, SunJ-S. Effect of dynamic compression on in vitro chondrocyte metabolism.Int J Artif Organs2008; 31(5): 439–49.
32.
WeinbergE., Kaazempur-MofradM., BorensteinJ.. Concept and computational design for a bioartificial nephron-on-a-chip.Int J Artif Organs2008; 31(6): 508–14.
33.
GawedaA.E., JacobsA.A., BrierM.E.. Application of fuzzy logic to predicting erythropoietic response in hemodialysis.Int J Artif Organs2008; 31(12): 1035–42.
34.
GiordanoC., CausaF., BiancoF., PeraleG., NettiP.A., AmbrosioL., CigadaA.. Gene delivery systems for gene therapy in tissue engineering and central nervous system applications.Int J Artif Organs2008; 31(12): 1017–26.
